ICU MEDICAL INC
ICUINASDAQTrading Snapshot
- Day Range
- $161.08 – $166.28
- 52-Week Range
- $112.50 – $192.85
- Volume
- $2.70B
- Avg Volume
- $2.99B
- Shares Outstanding
- 25.0M
- Next Earnings
- Nov 19, 2026
Fundamentals Snapshot
- Annual Revenue
- $2.23B
- Last Q Revenue
- $552M
- P/E Ratio
- 137.2
- P/S Ratio
- 1.9x
- EPS (TTM)
- $1.20
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +0.8%
Why Investors Own ICUI
- ✓High-growth profile — revenue up +51.6% YoY with expanding US Equity exposure.
- ✓Healthy economics — 29% gross margin and 22% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
ICU MEDICAL INC
ICUI
StockOtter · stockotter.spaceAbout ICU MEDICAL INC
ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
ICU MEDICAL INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift ICUI price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
ICU MEDICAL INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.